Tema Heart & Health ETF
Key Statistics
Historical Performance
Total return including reinvested distributions, from adjusted closing prices.
Price History
Price history is being compiled for this fund.
Top Holdings
Top 25 holdings as of Feb 28, 2026 · source: SEC N-PORT. Full holdings & prospectus →
About HRTS
Undernormal circumstances, the Fund seeks to achieve its investment objective by investing at least 80% of its net assets, which includeborrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or servicesrelated to GLP-1 and the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for DiseasesControl and Preventions (“CDC”). GLP-1 (glucagon-like peptide) is a class of drugs that can help manage diabetes andobesity. The Adviser will apply this definition to internal research and analysis based on company disclosure (such as 10-K filings,company presentations, capital markets day presentations) and other publicly available sources (e.g., sell-side research, biotechnologyindustry publications etc.) to make this assessment. Example companies include large pharmaceutical firms, development-stage biotechnologycompanies, diagnostic focused businesses with products used to diagnose and/or treat the aforementioned diseases, medical devicecompanies focused on treatment of the aforementioned diseases, and healthcare service providers with a specific strategic focuson helping treat and manage the aforementioned diseases, each providing they meet the aforementioned revenue test. TheFund generally is expected to consist of more than 15 companies but not more than 100 companies. The number of constituents maychange depending on the number of companies available for investment that meet the Fund’s criteria. Tobe eligible for inclusion in the Fund, a company must have a market capitalization of at least $100 million and there is no upperlimit on the market capitalization of a portfolio company. To be eligible for inclusion in the Fund, a company must have a three-monthaverage daily traded value of at least $500,000. Asignificant portion of the Fund’s assets are expected to be invested in the United States and Europe. TheFund will not engage in currency hedging and is expected to own foreign currency for short periods of time for the purposes ofbuying and selling non-US listed securities and collecting dividends and/or coupon payments from those securities. TheFund is classified as a “non-diversified” investment company under the Investment Company Act of 1940, as amended(the “1940 Act”), which means that it may invest a high percentage of its assets in a limited number of issuers andsectors. TheFund relies on the professional judgment of its Adviser to make decisions about the Fund’s portfolio investments. The basicinvestment philosophy of the Adviser is to seek to invest in growth companies within the aforementioned thematic universe thatare attractively valued when compared to their fundamentals and potential for earnings growth. The Adviser’s security selectionprocess for identifying companies within the aforementioned theme uses both “top down” idea generation (sector, theme,company research) and “bottom up” security selection (valuation, fundamental, quantitative, qualitative measures)approaches. Inpractice “top down” idea generation means fundamental sector research, quantitative tools (for example screening basedon metrics such as five-year historic revenue growth, margins, or returns on invested capital) and the Adviser’s own expertise,are used to narrow down the specific thematic research universe. Oncethis is defined “bottom up” security analysis involves the Adviser comparing valuation multiples (such as free cashflow yield, price to book ratio and price to earnings ratio or enterprise to total invested capital, among others) to fundamentalmetrics (such as organic revenue growth, margins, returns on invested capital and equity, among others). Investments are deemedattractively valued when compared to fundamentals if the valuation multiples are below and fundamentals are above either (1) peers(2) the companies own historic averages (3) or prospective forecasts (as determined by the Adviser). Buttressing this is a detailedfundamental research profile of each company assessing business model, competitive edge, management incentives and track record,and balance sheet. TheAdviser integrates environmental, social and corporate governance (“ESG”) considerations into its investment analysis.This is in support of both the objective of maximizing return and the broader analysis of risks associated with individual companies.The Adviser, however, does not use ESG considerations to limit, restrict or otherwise exclude companies or sectors from the Fund’sinvestment universe. ESGfactors in this context include, but are not limited to, the impact on or from climate change, natural resource use, waste managementpractices, human capital management, product safety, supply chain management, corporate governance, business ethics and advocacyfor governmental policy. TheAdviser may measure companies when considering ESG factors using sustainability data including scoring information that is providedby (i) the companies themselves, (ii) several third-party data providers (which are subject to change from time to time), including,but not limited to, Refinitiv, FactSet©, Trucost, Sustainalytics, SAM ESG Research and Persefoni and (iii) theAdviser itself. Whilethe Fund intends to seek select opportunities to actively engage with one or more portfolio companies, it may only be able todo so in limited circumstances and generally seek to indirectly influence the policies of portfolio companies through voting proxiesof such companies. The Fund seeks to encourage transformational change at the public companies within its portfolio through theapplication of these proxy voting guideline. Inmaking these considerations the Adviser will use both internal and external data sources and analyses including, but not limitedto, those provided by companies directly or by third parties. These considerations also inform monitoring of existing positions.To conduct this Analysis, the Adviser will use its own internal research and analysis, based on company materials (such as annualreports, websites, strategic and sell-side conference presentations) and other sources (publications focused on relevant industries,and external research by sell-side banks or consultancy firms. TheFund may invest in foreign securities listed on foreign exchanges as well as American Depositary Receipts (“ADRs”)and Global Depositary Receipts (“GDRs”). TheFund may invest in small-, mid- and large capitalization companies. TheFund may engage in securities lending.
HRTS News
- Understanding the Setup: (HRTS) and Scalable Risk
- (HRTS) Movement as an Input in Quant Signal Sets
- Tema Heart & Health ETF (NASDAQ:HRTS) Sees Significant Increase in Short Interest
- Tema Heart & Health ETF (NASDAQ:HRTS) Shares Up 0.2% – Should You Buy?
- Liquidity Mapping Around (HRTS) Price Events
- Why (HRTS) Price Action Is Critical for Tactical Trading
- Short Interest in Tema Heart & Health ETF (NASDAQ:HRTS) Decreases By 40.1%
- Why (HRTS) Price Action Is Critical for Tactical Trading
- Understanding Momentum Shifts in (HRTS)
- Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage
- Avoiding Lag: Real-Time Signals in (HRTS) Movement
- Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market
Data for HRTS is aggregated from third-party providers (Tiingo, Nasdaq, Finnhub) and SEC filings, may be delayed at least 20 minutes, and may be incomplete or contain errors. Nothing here is investment advice. Verify with the official prospectus before investing.